IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Trial record 3 of 4 for:
"Achlorhydria"
Evaluating Patients With Abnormal Levels of Gastric Acid
This study has been completed.
Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT00001240
First received: November 3, 1999
Last updated: March 4, 2008
Last verified: January 2004
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study is used by the Digestive Diseases Branch to evaluate patients with suspected abnormalities in the secretion of gastric acid. The level of gastric acid is measured by analyzing the gastric juices of each individual patient. The gastric acid sample is obtained by a procedure known as nasogastric suctioning, where a thin plastic tube is passed from the nose to the stomach.
Depending on the patient's present condition further diagnostic testing may be required to achieve a diagnosis.
| Condition |
|---|
| Achlorhydria Gastrinoma Zollinger Ellison Syndrome |
| Study Type: | Observational |
| Official Title: | Diagnostic Evaluation of Patients With Suspected Abnormalities of Gastric Secretion |
Resource links provided by NLM:
Further study details as provided by National Institutes of Health Clinical Center (CC):
| Study Start Date: | January 1989 |
| Estimated Study Completion Date: | January 2004 |
This study is an omnibus protocol used by the Digestive Diseases Branch to evaluate patients with suspected abnormalities of gastric acid secretion. Gastric acid secretion is measured by means of analysis of gastric juices obtained by nasogastric suction. Other clinically indicated diagnostic procedures are performed depending on the patient's clinical state in order to reach a diagnosis.
Eligibility| Ages Eligible for Study: | Child, Adult, Senior |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Criteria
Eligibility criteria not identified in the protocol.
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00001240
Please refer to this study by its ClinicalTrials.gov identifier: NCT00001240
Locations
| United States, Maryland | |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |
| Bethesda, Maryland, United States, 20892 | |
Sponsors and Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
More Information
Publications:
| ClinicalTrials.gov Identifier: | NCT00001240 History of Changes |
| Other Study ID Numbers: |
890005 89-DK-0005 |
| Study First Received: | November 3, 1999 |
| Last Updated: | March 4, 2008 |
Keywords provided by National Institutes of Health Clinical Center (CC):
|
Stomach Hypersecretion Hyposecretion Gastrinoma Zollinger-Ellison Syndrome |
Additional relevant MeSH terms:
|
Achlorhydria Zollinger-Ellison Syndrome Gastrinoma Paraneoplastic Endocrine Syndromes Paraneoplastic Syndromes Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Digestive System Diseases Gastrointestinal Diseases Peptic Ulcer Duodenal Diseases Intestinal Diseases |
Stomach Diseases Carcinoma, Islet Cell Adenocarcinoma Carcinoma Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Pancreatic Neoplasms Neoplasms by Site Endocrine Gland Neoplasms Pancreatic Diseases Endocrine System Diseases Acid-Base Imbalance Metabolic Diseases |
ClinicalTrials.gov processed this record on July 11, 2017